In ovarian cancers, Ronald L et al. revealed that the co-existence of an ARID1A-PIK3CA mutation promoted ovarian clear cell tumorigenesis by increasing the expression of IL-6 [6]. The gene discussed is ARID1A; the disease is ovarian carcinoma.